Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | IDO1 | P14902 | 3/20 | 0.40 |
| ▸ | GSK3B | P49841 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 6/20 | 0.35 |
| ▸ | GAA | P10253 | 4/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 3/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29960488 | 0.77 | IDO1 (0.51) | IDO1GSK3BMAPTGAAKDM4E | |
| Hydrochloric Acid SCHEMBL29959875 | 0.76 | IDO1 (0.50) | KMT2AIDO1GSK3BMAPTGAA | |
| SCHEMBL29960605 | 0.73 | IDO1 (0.41) | IDO1GSK3BMAPTGAAKDM4E | |
| Hydrochloric Acid SCHEMBL29960558 | 0.72 | IDO1 (0.40) | IDO1GSK3BMAPTGAAKDM4E | |
| SCHEMBL24692070 | 0.67 | HTR5A (0.58) | IDO1 | |
| SCHEMBL2878581 | 0.67 | HTR5A (0.58) | IDO1 | |
| SCHEMBL22972507 | 0.67 | IDO1 (0.43) | IDO1GSK3BMAPTGAAKDM4E | |
| SCHEMBL29713182 | 0.67 | HTR5A (0.58) | IDO1 | |
| SCHEMBL15867660 | 0.67 | MAPT (0.40) | KMT2AIDO1GSK3BTDP1MAPT | |
| SCHEMBL28321403 | 0.65 | HTR2A (0.48) | KMT2ATDP1MEN1TDO2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022204150-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |